Stempeutics’ allogeneic cell therapy gets DCGI approval, Cipla to market and distribute Stempeucel Read more
DCGI asks drug controllers to prevent sale, distribution of DEG contaminated cough syrup, Cofset Read more
Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData Read more
Serum Institute of India gets DCGI nod for phase 2 and 3 human trials of Oxford vaccine candidate Read more